JBCHEPHARM Historical Cash Flow
| JBCHEPHARM | 1,735 10.35 0.60% |
Analysis of JB Chemicals cash flow over time is an excellent tool to project JB Chemicals Pharmac future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 393.7 M or Depreciation of 1.5 B as it is a great indicator of JB Chemicals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining JB Chemicals Pharmac latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether JB Chemicals Pharmac is a good buy for the upcoming year.
JBCHEPHARM |
About JBCHEPHARM Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in JBCHEPHARM balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which JBCHEPHARM's non-liquid assets can be easily converted into cash.
JB Chemicals Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by JB Chemicals Pharmac to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of JB Chemicals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in JB Chemicals Pharmac financial statement analysis. It represents the amount of money remaining after all of JB Chemicals Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Most accounts from JB Chemicals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into JB Chemicals Pharmac current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in JB Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. As of now, JB Chemicals' Other Non Cash Items is increasing as compared to previous years. The JB Chemicals' current Total Cash From Operating Activities is estimated to increase to about 8.4 B, while Change To Inventory is forecasted to increase to (684.3 M).
JB Chemicals cash flow statement Correlations
Click cells to compare fundamentals
JB Chemicals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
JB Chemicals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (309.1M) | (700.9M) | (625.1M) | (205.2M) | (720.3M) | (684.3M) | |
| Change In Cash | (63.9M) | (32.8M) | 340.7M | 203.9M | 112.8M | 118.4M | |
| Free Cash Flow | 2.0B | 2.7B | (5.4B) | (1.4B) | 5.4B | 5.7B | |
| Change In Working Capital | 93.2M | (942.1M) | (3.0B) | (299.2M) | (1.4B) | (1.3B) | |
| Begin Period Cash Flow | 321.4M | 257.5M | 224.7M | 565.4M | 769.3M | 393.7M | |
| Other Cashflows From Financing Activities | (42.3M) | (141.8M) | (108.2M) | (55.8M) | (454.9M) | (432.1M) | |
| Depreciation | 663.2M | 686.7M | 726.6M | 1.1B | 1.4B | 1.5B | |
| Other Non Cash Items | (1.5B) | (2.6B) | 10.3M | 311.9M | 2.1B | 2.2B | |
| Dividends Paid | 1.4B | 732.4M | 1.3B | 1.3B | (1.6B) | (1.5B) | |
| Capital Expenditures | 729.7M | 477.7M | 7.1B | 7.6B | 2.6B | 1.6B | |
| Total Cash From Operating Activities | 2.8B | 3.1B | 1.7B | 6.3B | 8.0B | 8.4B | |
| Net Income | 3.5B | 6.0B | 5.0B | 5.6B | 5.5B | 3.0B | |
| Total Cash From Financing Activities | (3.1B) | (874.2M) | (1.4B) | 3.6B | (3.7B) | (3.6B) | |
| End Period Cash Flow | 257.5M | 224.7M | 565.4M | 769.3M | 882.2M | 926.3M | |
| Change To Account Receivables | (115.0M) | (706.0M) | (2.9B) | (417.5M) | (716M) | (751.8M) | |
| Investments | 912.6M | (2.2B) | 7.0B | (9.6B) | (4.0B) | (3.8B) | |
| Net Borrowings | (500K) | (23.6M) | (78.3M) | (83.7M) | (75.3M) | (71.5M) | |
| Total Cashflows From Investing Activities | 239.3M | (2.3B) | 23.2M | (9.6B) | (8.7B) | (8.2B) | |
| Other Cashflows From Investing Activities | 31.7M | 12.7M | 11.3M | (2.0B) | (1.8B) | (1.7B) | |
| Change To Netincome | (33.1M) | (723.2M) | (1.1B) | 146.4M | 131.7M | 138.3M | |
| Change To Liabilities | (285.7M) | 521.1M | 464.8M | 528.3M | 607.6M | 638.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in JBCHEPHARM Stock
The Cash Flow Statement is a financial statement that shows how changes in JBCHEPHARM balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which JBCHEPHARM's non-liquid assets can be easily converted into cash.